DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·07/16/2025 12:08:15
Listen to the news

Gainers

  • Nuwellis (NASDAQ:NUWE) shares rose 146.7% to $17.01 during Wednesday's pre-market session. The market value of their outstanding shares is at $30.1 million.
  • Citius Oncology (NASDAQ:CTOR) shares moved upwards by 19.15% to $1.83. The company's market cap stands at $110.1 million.
  • Abivax (NASDAQ:ABVX) shares rose 15.81% to $10.25. The company's market cap stands at $561.7 million.
  • Repare Therapeutics (NASDAQ:RPTX) shares increased by 13.28% to $1.62. The market value of their outstanding shares is at $61.3 million.
  • Crescent Biopharma (NASDAQ:CBIO) stock increased by 9.4% to $12.85. The market value of their outstanding shares is at $229.0 million.
  • Inspire Veterinary (NASDAQ:IVP) shares increased by 9.04% to $0.71. The company's market cap stands at $1.6 million.

Losers

  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares declined by 32.9% to $8.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $19.5 million.
  • Lixte Biotechnology (NASDAQ:LIXT) shares declined by 27.23% to $2.7. The company's market cap stands at $11.2 million.
  • Kairos Pharma (AMEX:KAPA) shares declined by 22.65% to $0.91. The market value of their outstanding shares is at $19.7 million.
  • Gain Therapeutics (NASDAQ:GANX) shares fell 15.3% to $1.44. The market value of their outstanding shares is at $50.2 million.
  • Celularity (NASDAQ:CELU) shares declined by 13.31% to $2.15. The company's market cap stands at $59.3 million.
  • Mainz Biomed (NASDAQ:MYNZ) stock fell 12.63% to $1.73. The company's market cap stands at $7.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.